CN Patent

CN110872269B — 一种环己烷衍生物的盐

Assigned to Shanghai Jingxin Biological Medical Co ltd · Expires 2024-06-07 · 2y expired

What this patent protects

本发明涉及一种如式I所示化合物环己烷衍生物N′‑[反式‑4‑[2‑[7‑(苯并[b]噻吩)‑7‑哌嗪基]乙基]环己基]‑N，N‑二甲基脲的马来酸盐及其晶型。该晶型引湿性低，稳定性好，便于长期存储和运输；体内实验还证明，其半衰期长，生物利用度高、个体差异性小。

USPTO Abstract

本发明涉及一种如式I所示化合物环己烷衍生物N′‑[反式‑4‑[2‑[7‑(苯并[b]噻吩)‑7‑哌嗪基]乙基]环己基]‑N，N‑二甲基脲的马来酸盐及其晶型。该晶型引湿性低，稳定性好，便于长期存储和运输；体内实验还证明，其半衰期长，生物利用度高、个体差异性小。

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN110872269B
Jurisdiction: CN
Classification: —
Expires: 2024-06-07
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Jingxin Biological Medical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.